Dr. Chandran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
G3252 Beecher Rd
Pulmonary & Critical Care Cec404 Dcd43.00
Flint, MI 48532Phone+1 810-230-6800
Education & Training
- University of Missouri-ColumbiaFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
- University of Missouri-ColumbiaResidency, Internal Medicine, 2010 - 2013
- PSG Institute of Medical SciencesClass of 2002
Certifications & Licensure
- MI State Medical License 2016 - 2026
- MO State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 19 citationsC1q Nephropathy: The Unique Underrecognized Pathological Entity.Joe Devasahayam, Gowrishankar Erode-Singaravelu, Zeenat Bhat, Tony Oliver, Arul Chandran
Analytical Cellular Pathology. 2015-11-10 - 37 citationsDupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials.Yazan Zayed, Babikir Kheiri, Momen Banifadel, Michael Hicks, Ahmed Aburahma
The Journal of Asthma. 2019-10-01 - 7 citationsLong-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysisYuji Oba, Arul Chandran, Joe Devasahayam
COPD. 2016-05-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: